期刊文献+

Flt3-L是否为体外制备急性髓系白血病患者DC瘤苗的更佳选择?

The differences between Flt3-ligand and GM-CSF in inducing dendritic cells from acute myeloid leukemia patients' bone marrow
暂未订购
导出
摘要 目的:通过对体外使用Flt3-L(FL)及粒-巨噬细胞集落刺激因子(GM-CSF)诱导完全缓解期急性髓系白血病(AML-CR)患者的骨髓中单个核细胞(BMNC)分化为树突状细胞(DC)、分泌白介素(IL-12P70),干扰素-α(INF-α)的情况,及所诱导DC体外刺激自体T细胞(auto-T cells)活化增殖能力的观察,进一步了解FL在DC瘤苗制备中的作用特点。方法:分离AML-CR患者BMNC采用FL/GM-CSF单因子培养于RPMI1640完全培养基中至第8天,加入LPS刺激活化后流式细胞仪明确DC免疫表型,ELISA法测定培养液上清中IL-12P70、INF-α,收集阳性细胞体外激发增埴auto-T细胞,MTT法测试T细胞增殖情况。结果:10例AML患者的BMNC经FL/GM-CSF分别培养至第72 h均开始有细胞成簇生长,流式细胞检测显示CD1a、CD83、CD80、CD86、HLA-DR均表达明显上调,ELISA测定FL组IL-12P70,INF-α分泌量较GM-CSF组有显著增加。2组均可产生较强的T细胞增殖效应,与GM-CSF比,FL组对CD4+T细胞的增殖作用更强。结论:在体外,FL可更强诱导AML-CR患者BMNC产生DC,同时分泌大量IL-12P70及INF-α。故与GM-CSF相比,FL可能具有更佳的抗肿瘤免疫作用。 Objective:To study the differences of FL and GM-CSF expanding dendritic cells derived from AML- CR patients' bone marrow and the capacity of stimulating auto-T cells in vitro. Method:The bone marrow mononu- clear cells from AMLCR patients were cultured in RPMI1640 medium contained FL/GM-CSF; After 8 days, the cells were stimulated with LPS. When mature, they were analyzed for immuno-phenotype and IL-12, INF a by ELISA. Finally the DCs were used in auto-genic T cells test. Result: In all cases, a significant proportion of cells started to show DCs morphology in 3 days with different dose FL or GM-CSF. After activation, the ceils up-modulate CD1α/CD83 and CD80,CD86, HLA-DR significantly, and have potential in stimulating auto-T cells, but FL expand Th2 cells more efficient. Conclusion: Compared with GM CSF, FL could more powerfully enhance DCs from the bone marrow of AML-CR patients. These DCs have the capability to produce a great amount of IL- 12P70,INF-α and preferentially stimulate auto-T cells ex-vivo.
出处 《临床血液学杂志》 CAS 2006年第3期155-157,共3页 Journal of Clinical Hematology
关键词 白血病 髓细胞性 急性 树突状细胞 Flt3-L GM CSF Dendritic cells Acute Myeloid leukemia Flt3 ligand GM CSF
  • 相关文献

参考文献11

  • 1Peter Brossart,Stefan Wirths,Wolfman Bruggen,et al.Dentritic cells in cancer vaccines Experimental He matology,2001,29:1247-1255.
  • 2Pulendran B,Smith J L,Caspary G,et al.Distinct dendritic cell subsets differentially regulate the class of immune response in vivo.Pro Natl Acad Sci USA,1999,96:1036-1041.
  • 3MeKenna H J,Stocking K L,Miller R E,et al.Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells,dendritic cells,and natural killer cells.Blood,2000,95:3489-3497.
  • 4Farrar J C,Murphy K M.Type Ⅰ interferons and T helper development.Immunol Today,2000,10:484-489.
  • 5Akbar A N,Lord J M,et al.INF-alpha and INF-belta:a link between immune memory and chronic inflammation.Immunol Today,2000,7:337-342.
  • 6Kayapaki N,Yamaguchi N,Antonenko S,et al.Type Ⅰ interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) expression on human T cells:a novel mechanism for the antitumor effects of type Ⅰ IFNs.J Exp Med,1999,189:1451-1460.
  • 7Kenneth Brasel,Thibaut De Smedt,Jeffery L.Smith,and Charles R Maliszewski:Generation of murine dendritic cells from flt3-ligand-supplementebonemarrowcultures.Blood,2000,96:3029-3039.
  • 8Brasel K,Maraskovsky E,Pulendran B,et al.Preferential expansion of myeloidtyp dendritic cells in vivo after administration of GM-CSF into mice:a comparative analysis with Flt3 ligand generated dedritic cells.Blood,1997,90:170a-170a.
  • 9Maraskovsky E,Brasel K,Teepe M,et al.Dramatic increase in the numbers of functionally mature dendritic cells in the flt3 ligand-treated mice:multiple dendritic cells populations identified.J Exp Med,1996,184:1953-1962.
  • 10Hanada K,Tsunoda R,Hamada H.GM-CSF induced in vivo expansion of splenic dendritic cells and their strong costimulation activity.J leukoc Biol,1996,60:181-190.

二级参考文献7

  • 1Santiago-Schwartz F, Belilos E, Diamond B, et al.TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol, 1992,52: 274-281.
  • 2Reid C D L, Stackpoole A, Meager A, et al. Interaction of tumor necrosis factor with granulocyte-macrophage colony stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bo
  • 3Pickl W F,Majdic O,Kohl P,et al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14 + peripheral blood monocytes. J Immunol, 1996, 157: 3850-3859.
  • 4Robinson S P, English N, Jaju R, et al. The in -vitro generation of dendritic cells from blast cells in acute leukemia. Br J Haematol, 1998,103:763-771.
  • 5Choudhury A, Liang J C, Thomas E K, et al. Dendritic cells derived in vitro from acute myelogeneous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood, 1999,93:780-788.
  • 6Re F, Arpinatic M, Testonic N, et al. Expression of CD86 in acute myelogenous leukemia is a marker of dendriti/monocytic lineage. Exp Hematol, 2002,30: 126-134.
  • 7Caux C, Dezutter-Dambuyant C, Scmitt D, et al. GMCSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature, 1992,360: 258-261.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部